4//SEC Filing
Krieger Nancy 4
Accession 0000899243-22-004203
CIK 0001827506other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 6:02 PM ET
Size
5.4 KB
Accession
0000899243-22-004203
Insider Transaction Report
Form 4
Krieger Nancy
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-02-01+190,000→ 190,000 totalExercise: $9.10Exp: 2032-01-31→ Common Stock (190,000 underlying)
Footnotes (1)
- [F1]The shares underlying this option shall vest as follows: 25% shall vest on February 1, 2023; and the remaining shall vest in 36 equal monthly installments thereafter.
Documents
Issuer
Talaris Therapeutics, Inc.
CIK 0001827506
Entity typeother
Related Parties
1- filerCIK 0001845672
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 6:02 PM ET
- Size
- 5.4 KB